Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             197 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acknowledgements 2012
30 Supplement 3 p. vii-
1 p.
artikel
2 Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice Seregin, Sergey S.
2012
30 Supplement 3 p. 1492-1501
10 p.
artikel
3 Adjuvant effect of Japanese herbal medicines on the mucosal type 1 immune responses to human papillomavirus (HPV) E7 in mice immunized orally with Lactobacillus-based therapeutic HPV vaccine in a synergistic manner Taguchi, Ayumi
2012
30 Supplement 3 p. 5368-5372
5 p.
artikel
4 A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children Anh, Dang Duc
2012
30 Supplement 3 p. A114-A121
nvt p.
artikel
5 Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010 Ouandaogo, Claude-Roger
2012
30 Supplement 3 p. B46-B51
nvt p.
artikel
6 A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed Pajewski, Nicholas M.
2012
30 Supplement 3 p. 4778-4784
7 p.
artikel
7 An alternative signal 3: CD8+ T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling Sanchez, Phillip J.
2012
30 Supplement 3 p. 1154-1161
8 p.
artikel
8 Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine Breiman, Robert F.
2012
30 Supplement 3 p. A24-A29
nvt p.
artikel
9 An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China Yin, Zundong
2012
30 Supplement 3 p. 5569-5577
9 p.
artikel
10 A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory Loew-Baselli, Alexandra
2012
30 Supplement 3 p. 5956-5966
11 p.
artikel
11 An update on human papillomavirus vaccine uptake among 11–17 year old girls in the United States: National Health Interview Survey, 2010 Laz, Tabassum H.
2012
30 Supplement 3 p. 3534-3540
7 p.
artikel
12 A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil Weckx, Lily Yin
2012
30 Supplement 3 p. 7566-7572
7 p.
artikel
13 A possible relationship of natural killer T cells with humoral immune response to 23-valent pneumococcal polysaccharide vaccine in clinical settings Miyasaka, Tomomitsu
2012
30 Supplement 3 p. 3304-3310
7 p.
artikel
14 A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age Baxter, Roger
2012
30 Supplement 3 p. 2989-2998
10 p.
artikel
15 A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations Hatz, Christoph
2012
30 Supplement 3 p. 4820-4827
8 p.
artikel
16 A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity Hoft, Daniel F.
2012
30 Supplement 3 p. 2098-2108
11 p.
artikel
17 A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines Schiller, John T.
2012
30 Supplement 3 p. F123-F138
nvt p.
artikel
18 A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain Thibodeaux, Brett A.
2012
30 Supplement 3 p. 3180-3187
8 p.
artikel
19 Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs Sanford, Brenton J.
2012
30 Supplement 3 p. 6249-6255
7 p.
artikel
20 A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009–2010 season Tennis, Patricia
2012
30 Supplement 3 p. 6099-6102
4 p.
artikel
21 Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1) Nayak, Baibaswata
2012
30 Supplement 3 p. 2220-2227
8 p.
artikel
22 Barriers to HPV immunization for African American adolescent females Hamlish, Tamara
2012
30 Supplement 3 p. 6472-6476
5 p.
artikel
23 Baseline hepatitis B vaccination coverage among persons with diabetes before implementing a U.S. recommendation for vaccination Byrd, Kathy K.
2012
30 Supplement 3 p. 3376-3382
7 p.
artikel
24 Birth order and private voluntary immunization—A study of 110,902 children Gavrielov-Yusim, Natalie
2012
30 Supplement 3 p. 442-447
6 p.
artikel
25 Bovine tuberculosis vaccine research: Historical perspectives and recent advances Waters, W. Ray
2012
30 Supplement 3 p. 2611-2622
12 p.
artikel
26 Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine Moffitt, Kristin L.
2012
30 Supplement 3 p. 4316-4322
7 p.
artikel
27 Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) Loughlin, Anita M.
2012
30 Supplement 3 p. 7253-7259
7 p.
artikel
28 Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice Dendouga, Najoua
2012
30 Supplement 3 p. 3126-3135
10 p.
artikel
29 Challenge with a hepatitis B vaccine in two cohorts of 4–7-year-old children primed with hexavalent vaccines: An open-label, randomised trial in Italy Zanetti, Alessandro
2012
30 Supplement 3 p. 5770-5775
6 p.
artikel
30 Characterisation of vaccine-induced, broadly cross-reactive IFN-γ secreting T cell responses that correlate with rapid protection against classical swine fever virus Graham, Simon P.
2012
30 Supplement 3 p. 2742-2748
7 p.
artikel
31 Characteristics of serology-based vaccine potency models for foot-and-mouth disease virus Willems, Tom
2012
30 Supplement 3 p. 5849-5855
7 p.
artikel
32 Characterizing providers’ immunization communication practices during health supervision visits with vaccine-hesitant parents: A pilot study Opel, Douglas J.
2012
30 Supplement 3 p. 1269-1275
7 p.
artikel
33 Chemotypical variations in Withania somnifera lead to differentially modulated immune response in BALB/c mice Kushwaha, Susheela
2012
30 Supplement 3 p. 1083-1093
11 p.
artikel
34 Colostrum from cattle immunized with a vaccine based on iron regulated proteins of Mannheimia haemolytica confers partial protection Makoschey, B.
2012
30 Supplement 3 p. 969-973
5 p.
artikel
35 Combination vaccines in the South African setting Visser, Adele
2012
30 Supplement 3 p. C38-C44
nvt p.
artikel
36 Comparative immunogenicity and safety of different multivalent component pertussis vaccine formulations and a 5-component acellular pertussis vaccine in infants and toddlers: A randomized, controlled, open-label, multicenter study Chatterjee, Archana
2012
30 Supplement 3 p. 3360-3368
9 p.
artikel
37 Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity Gregory, A.E.
2012
30 Supplement 3 p. 6777-6782
6 p.
artikel
38 Construction and immune effect of Haemophilus parasuis DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mice Fu, Shulin
2012
30 Supplement 3 p. 6839-6844
6 p.
artikel
39 Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands Meijboom, M.J.
2012
30 Supplement 3 p. 4691-4700
10 p.
artikel
40 Current issues with the immunization program in Japan: Can we fill the “vaccine gap”? Saitoh, Akihiko
2012
30 Supplement 3 p. 4752-4756
5 p.
artikel
41 Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain Altman, Eleonora
2012
30 Supplement 3 p. 7332-7341
10 p.
artikel
42 Development of sipuleucel-T: Autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer Sims, Robert B.
2012
30 Supplement 3 p. 4394-4397
4 p.
artikel
43 Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response Taylor, David N.
2012
30 Supplement 3 p. 5761-5769
9 p.
artikel
44 Direct and indirect impact of influenza vaccination of young children on school absenteeism King Jr., James C.
2012
30 Supplement 3 p. 289-293
5 p.
artikel
45 Early infection dynamics after experimental challenge with Mycobacterium avium subspecies paratuberculosis in calves reveal limited calf-to-calf transmission and no impact of Hsp70 vaccination Santema, Wiebren J.
2012
30 Supplement 3 p. 7032-7039
8 p.
artikel
46 Economic analysis for evidence-based policy-making on a national immunization program: A case of rotavirus vaccine in Thailand Muangchana, Charung
2012
30 Supplement 3 p. 2839-2847
9 p.
artikel
47 Economic evaluation of vaccination programme of 7-valent pneumococcal conjugate vaccine to the birth cohort in Japan Hoshi, Shu-ling
2012
30 Supplement 3 p. 3320-3328
9 p.
artikel
48 Editorial Board 2012
30 Supplement 3 p. CO2-
1 p.
artikel
49 Editorial Board 2011
30 Supplement 3 p. CO2-
1 p.
artikel
50 Editorial Board 2012
30 Supplement 3 p. CO2-
1 p.
artikel
51 Editorial Board 2012
30 Supplement 3 p. CO2-
1 p.
artikel
52 Editorial Board/Aims and Scope 2012
30 Supplement 3 p. CO2-
1 p.
artikel
53 Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience Djingarey, Mamoudou H.
2012
30 Supplement 3 p. B40-B45
nvt p.
artikel
54 Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain Castilla, Jesús
2012
30 Supplement 3 p. 539-543
5 p.
artikel
55 Effects of immunization with natural and recombinant lysine decarboxylase on canine gingivitis development Peters, Jennifer L.
2012
30 Supplement 3 p. 6706-6712
7 p.
artikel
56 Efficacy of an AS03A-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs De Vleeschauwer, Annebel R.
2012
30 Supplement 3 p. 5557-5563
7 p.
artikel
57 Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions Seo, Hwi Won
2012
30 Supplement 3 p. 6671-6677
7 p.
artikel
58 Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo controlled trial Cunliffe, Nigel A.
2012
30 Supplement 3 p. A36-A43
nvt p.
artikel
59 Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya Feikin, Daniel R.
2012
30 Supplement 3 p. A52-A60
nvt p.
artikel
60 Efficacy of the oral pentavalent rotavirus vaccine in Mali Sow, Samba O.
2012
30 Supplement 3 p. A71-A78
nvt p.
artikel
61 Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer Zhu, Daming
2012
30 Supplement 3 p. 189-194
6 p.
artikel
62 Eliciting broad neutralizing antibody to HIV-1: Envelopes of different lentivirus cross immunization by prime-boost vaccination Luo, Zhenwu
2012
30 Supplement 3 p. 5316-5323
8 p.
artikel
63 Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009–2010 Seyler, Thomas
2012
30 Supplement 3 p. 109-111
3 p.
artikel
64 Estimating the age-specific duration of herpes zoster vaccine protection: A matter of model choice? Bilcke, Joke
2012
30 Supplement 3 p. 2795-2800
6 p.
artikel
65 Evaluating associations between sources of information, knowledge of the human papillomavirus, and human papillomavirus vaccine uptake for adult women in California Almeida, Cristina M.
2012
30 Supplement 3 p. 3003-3008
6 p.
artikel
66 Evaluation of a toolkit to introduce standing orders for influenza and pneumococcal vaccination in adults: A multimodal pilot project Nowalk, Mary Patricia
2012
30 Supplement 3 p. 5978-5982
5 p.
artikel
67 Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: Interim analysis Bettinger, Julie A.
2012
30 Supplement 3 p. 4023-4027
5 p.
artikel
68 Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice Sislema-Egas, Fernanda
2012
30 Supplement 3 p. 7286-7291
6 p.
artikel
69 Evaluation of the humoral immune response in adult dairy cattle three years after vaccination with a bluetongue serotype 8 inactivated vaccine Oura, C.A.L.
2012
30 Supplement 3 p. 112-115
4 p.
artikel
70 Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children Karron, Ruth A.
2012
30 Supplement 3 p. 3975-3981
7 p.
artikel
71 Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer Arbyn, Marc
2012
30 Supplement 3 p. F88-F99
nvt p.
artikel
72 Factors associated with HPV vaccine uptake in teenage girls: A systematic review Kessels, Sharon J.M.
2012
30 Supplement 3 p. 3546-3556
11 p.
artikel
73 Factors influencing pandemic influenza vaccination of healthcare workers—A systematic review Prematunge, Chatura
2012
30 Supplement 3 p. 4733-4743
11 p.
artikel
74 Feasibility of a randomized controlled trial to evaluate Text Reminders for Immunization Compliance in Kids (TRICKs) Ahlers-Schmidt, Carolyn R.
2012
30 Supplement 3 p. 5305-5309
5 p.
artikel
75 Flaviviruses and flavivirus vaccines Heinz, Franz X.
2012
30 Supplement 3 p. 4301-4306
6 p.
artikel
76 Formulation and evaluation of oral microparticulate ovarian cancer vaccines Tawde, Suprita A.
2012
30 Supplement 3 p. 5675-5681
7 p.
artikel
77 Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway Su, Fei
2012
30 Supplement 3 p. 4106-4112
7 p.
artikel
78 Global Burden of Human Papillomavirus and Related Diseases Forman, David
2012
30 Supplement 3 p. F12-F23
nvt p.
artikel
79 Health economics of rotavirus immunization in Vietnam: Potentials for favorable cost-effectiveness in developing countries Tu, Hong-Anh T.
2012
30 Supplement 3 p. 1521-1528
8 p.
artikel
80 Heteroclitic peptides enhance human immunodeficiency virus-specific CD8+ T cell responses Gladney, Krista H.
2012
30 Supplement 3 p. 6997-7004
8 p.
artikel
81 Homologous whole bacterin vaccination is not able to reduce Streptococcus suis serotype 9 strain 7997 transmission among pigs or colonization Dekker, C.N.T.
2012
30 Supplement 3 p. 1379-1387
9 p.
artikel
82 Host immune response to A(H1N1)pdm09 vaccination and infection: A one-year prospective study on six cohorts of subjects Liu, Wei
2012
30 Supplement 3 p. 4785-4789
5 p.
artikel
83 Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization Smith, Kenneth
2012
30 Supplement 3 p. 4276-4283
8 p.
artikel
84 Human Papillomavirus Vaccine Introduction – The First Five Years Markowitz, Lauri E.
2012
30 Supplement 3 p. F139-F148
nvt p.
artikel
85 Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine Tomovici, A.
2012
30 Supplement 3 p. 2647-2653
7 p.
artikel
86 Immunity to tetanus and diphtheria in the UK in 2009 Wagner, Karen S.
2012
30 Supplement 3 p. 7111-7117
7 p.
artikel
87 Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice Brewoo, Joseph N.
2012
30 Supplement 3 p. 1513-1520
8 p.
artikel
88 Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine Porter, Kevin R.
2012
30 Supplement 3 p. 336-341
6 p.
artikel
89 Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers Klein, Nicola P.
2012
30 Supplement 3 p. 3929-3936
8 p.
artikel
90 Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad®) in infants from 9 months of age Vesikari, Timo
2012
30 Supplement 3 p. 3082-3089
8 p.
artikel
91 Immunogenicity and safety of tetravalent dengue vaccine in 2–11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru Lanata, Claudio F.
2012
30 Supplement 3 p. 5935-5941
7 p.
artikel
92 Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age Van Der Meeren, Olivier
2012
30 Supplement 3 p. 2710-2714
5 p.
artikel
93 Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine Woolpert, Tabitha
2012
30 Supplement 3 p. 3090-3096
7 p.
artikel
94 Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam Shin, Sunheang
2012
30 Supplement 3 p. A106-A113
nvt p.
artikel
95 Immunogenicity of the pentavalent rotavirus vaccine in African infants Armah, George E.
2012
30 Supplement 3 p. A86-A93
nvt p.
artikel
96 Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis Dell’Era, Laura
2012
30 Supplement 3 p. 936-940
5 p.
artikel
97 Immunological impact of an additional early measles vaccine in Gambian children: Responses to a boost at 3 years Njie-Jobe, Jainaba
2012
30 Supplement 3 p. 2543-2550
8 p.
artikel
98 Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales Andrews, Nick J.
2012
30 Supplement 3 p. 6802-6808
7 p.
artikel
99 Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: An overview from Kuwait Mokaddas, Eiman
2012
30 Supplement 3 p. G37-G40
nvt p.
artikel
100 Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme Ingels, Helene
2012
30 Supplement 3 p. 3944-3950
7 p.
artikel
101 Impact of postpartum information about pertussis booster to parents in a university maternity hospital Leboucher, Bertrand
2012
30 Supplement 3 p. 5472-5481
10 p.
artikel
102 Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy Bechini, Angela
2012
30 Supplement 3 p. 6396-6401
6 p.
artikel
103 Implementation of a hepatitis A/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County Jail, 2007–2010 Costumbrado, John
2012
30 Supplement 3 p. 6878-6882
5 p.
artikel
104 Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge Morello, Christopher S.
2012
30 Supplement 3 p. 6541-6550
10 p.
artikel
105 Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: Improvement of production parameters and interaction with maternally derived immunity Fraile, Lorenzo
2012
30 Supplement 3 p. 1986-1992
7 p.
artikel
106 Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge Cox, Josephine H.
2012
30 Supplement 3 p. 1830-1840
11 p.
artikel
107 International collaborative proficiency study of Human Papillomavirus type 16 serology Eklund, Carina
2012
30 Supplement 3 p. 294-299
6 p.
artikel
108 Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling Winkelmann, Evandro R.
2012
30 Supplement 3 p. 1465-1475
11 p.
artikel
109 Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine Anhlan, Darisuren
2012
30 Supplement 3 p. 4480-4489
10 p.
artikel
110 In vitro derivation of interferon-γ producing, IL-4 and IL-7 responsive memory-like CD4+ T cells Comber, Joseph D.
2012
30 Supplement 3 p. 2140-2145
6 p.
artikel
111 Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses Roth, Bernhard
2012
30 Supplement 3 p. 517-522
6 p.
artikel
112 Lack of association between childhood immunizations and encephalitis in California, 1998–2008 Pahud, Barbara A.
2012
30 Supplement 3 p. 247-253
7 p.
artikel
113 Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis Shargh, Vahid Heravi
2012
30 Supplement 3 p. 3957-3964
8 p.
artikel
114 Long-term efficacy of 10–12 years after being immunized with Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities Wang, Feng
2012
30 Supplement 3 p. 2051-2053
3 p.
artikel
115 Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh Feller, Andrea J.
2012
30 Supplement 3 p. A101-A105
nvt p.
artikel
116 Maternal knowledge, attitudes and beliefs regarding gastroenteritis and rotavirus vaccine before implementing vaccination program: Which key messages in light of a new immunization program? Morin, Alyssa
2012
30 Supplement 3 p. 5921-5927
7 p.
artikel
117 Measles, mumps, and rubella virus vaccine (M–M–R™II): A review of 32 years of clinical and postmarketing experience Lievano, Fabio
2012
30 Supplement 3 p. 6918-6926
9 p.
artikel
118 Measuring bovine viral diarrhea virus vaccine response: Using a commercially available ELISA as a surrogate for serum neutralization assays Gonda, M.G.
2012
30 Supplement 3 p. 6559-6563
5 p.
artikel
119 Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh Zaman, K.
2012
30 Supplement 3 p. A94-A100
nvt p.
artikel
120 Molecular epidemiology of circulating highly pathogenic avian influenza (H5N1) virus in chickens, in Bangladesh, 2007–2010 Ahmed, Syed Sayeem Uddin
2012
30 Supplement 3 p. 7381-7390
10 p.
artikel
121 Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially Pissani, Franco
2012
30 Supplement 3 p. 5519-5526
8 p.
artikel
122 Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice Flach, Carl-Fredrik
2012
30 Supplement 3 p. 1636-1643
8 p.
artikel
123 Multi-antigenic vaccine against the cattle tick Rhipicephalus (Boophilus) microplus: A field evaluation Parizi, Luís F.
2012
30 Supplement 3 p. 6912-6917
6 p.
artikel
124 Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics Tiro, Jasmin A.
2012
30 Supplement 3 p. 2368-2375
8 p.
artikel
125 NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults Schmidt, Clint S.
2012
30 Supplement 3 p. 7594-7600
7 p.
artikel
126 Neonatal revaccination with Bacillus Calmette–Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice Li, Wen
2012
30 Supplement 3 p. 3223-3230
8 p.
artikel
127 Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: A 10-year study Charfi, F.
2012
30 Supplement 3 p. G18-G24
nvt p.
artikel
128 Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice Nanjundappa, Roopa Hebbandi
2012
30 Supplement 3 p. 3519-3525
7 p.
artikel
129 One clinic visit for pre-exposure rabies vaccination (a preliminary one year study) Khawplod, Pakamatz
2012
30 Supplement 3 p. 2918-2920
3 p.
artikel
130 One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies Faenzi, Elisa
2012
30 Supplement 3 p. 4086-4094
9 p.
artikel
131 Parental and societal values for the risks and benefits of childhood combination vaccines Gidengil, Courtney
2012
30 Supplement 3 p. 3445-3452
8 p.
artikel
132 Persistence of long-term immunity to hepatitis B among adolescents immunized at birth Chaves, Sandra S.
2012
30 Supplement 3 p. 1644-1649
6 p.
artikel
133 Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations Khatami, Ameneh
2012
30 Supplement 3 p. 2831-2838
8 p.
artikel
134 Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: Analyses of 10 years of pertussis surveillance Nilsson, Lennart
2012
30 Supplement 3 p. 3239-3247
9 p.
artikel
135 Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide Zollinger, Wendell D.
2012
30 Supplement 3 p. 712-721
10 p.
artikel
136 Pneumococcal polysaccharide 23-valent vaccine: Long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults Grabenstein, John D.
2012
30 Supplement 3 p. 4435-4444
10 p.
artikel
137 Pneumococcal vaccines WHO position paper – 2012 – Recommendations WHO Publication,
2012
30 Supplement 3 p. 4717-4718
2 p.
artikel
138 Post-exposure immunization against Francisella tularensis membrane proteins augments protective efficacy of gentamicin in a mouse model of pneumonic tularemia Sutherland, Marjorie D.
2012
30 Supplement 3 p. 4977-4982
6 p.
artikel
139 Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: Quantification using a multi-type mathematical model Choi, Yoon Hong
2012
30 Supplement 3 p. 3383-3388
6 p.
artikel
140 Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children Azzari, Chiara
2012
30 Supplement 3 p. 2701-2705
5 p.
artikel
141 Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka de Silva, Rajiva
2012
30 Supplement 3 p. 7561-7565
5 p.
artikel
142 Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: A review Jauneikaite, E.
2012
30 Supplement 3 p. 3503-3514
12 p.
artikel
143 Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines Monsonego, Joseph
2012
30 Supplement 3 p. 5215-5221
7 p.
artikel
144 Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi Micoli, F.
2012
30 Supplement 3 p. 853-861
9 p.
artikel
145 Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants Isken, B.
2012
30 Supplement 3 p. 5253-5261
9 p.
artikel
146 Progressive changes in pneumococcal carriage in children attending daycare in Portugal after 6 years of gradual conjugate vaccine introduction show falls in most residual vaccine serotypes but no net replacement or trends in diversity Rodrigues, Fernanda
2012
30 Supplement 3 p. 3951-3956
6 p.
artikel
147 Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica Arguedas, Adriano
2012
30 Supplement 3 p. 2342-2348
7 p.
artikel
148 Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant Gordon, David L.
2012
30 Supplement 3 p. 5407-5416
10 p.
artikel
149 Randomized placebo-controlled clinical trial of immunoglobulin Y as adjunct to standard supportive therapy for rotavirus-associated diarrhea among pediatric patients Rahman, Shofiqur
2012
30 Supplement 3 p. 4661-4669
9 p.
artikel
150 Randomized trial of HPV4 vaccine assessing the response to HPV4 vaccine in two schedules among Peruvian female sex workers Brown, Brandon
2012
30 Supplement 3 p. 2309-2314
6 p.
artikel
151 Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel Ben-Shimol, S.
2012
30 Supplement 3 p. 6600-6607
8 p.
artikel
152 Reduction of high pathogenicity avian influenza virus in eggs from chickens once or twice vaccinated with an oil-emulsified inactivated H5 avian influenza vaccine Swayne, David E.
2012
30 Supplement 3 p. 4964-4970
7 p.
artikel
153 Reframing Cervical Cancer Prevention. Expanding the Field Towards Prevention of Human Papillomavirus Infections and Related Diseases Bosch, F. Xavier
2012
30 Supplement 3 p. F1-F11
nvt p.
artikel
154 Report of the ad-hoc consultation on aging and immunization for a future WHO research agenda on life-course immunization Thomas-Crusells, Judith
2012
30 Supplement 3 p. 6007-6012
6 p.
artikel
155 Research priorities for global measles and rubella control and eradication Goodson, James L.
2012
30 Supplement 3 p. 4709-4716
8 p.
artikel
156 Respiratory viruses transmission from children to adults within a household MacIntyre, Chandini Raina
2012
30 Supplement 3 p. 3009-3014
6 p.
artikel
157 Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders Hoebe, Christian J.P.A.
2012
30 Supplement 3 p. 6734-6737
4 p.
artikel
158 Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States Krishnarajah, Girishanthy
2012
30 Supplement 3 p. 3717-3722
6 p.
artikel
159 Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates Minervini, Gianmaria
2012
30 Supplement 3 p. 1476-1480
5 p.
artikel
160 Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: Data from two multicentre randomised trials Peeters, Mathieu
2012
30 Supplement 3 p. 6483-6491
9 p.
artikel
161 Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens Stanberry, L.R.
2012
30 Supplement 3 p. 307-316
10 p.
artikel
162 Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults Seiberling, Michael
2012
30 Supplement 3 p. 7455-7460
6 p.
artikel
163 Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: A randomized, double-blind, placebo-controlled trial in Chinese males and females Li, Rongcheng
2012
30 Supplement 3 p. 4284-4291
8 p.
artikel
164 Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults Halperin, Scott A.
2012
30 Supplement 3 p. 5445-5448
4 p.
artikel
165 Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq®, in Kenya, including among HIV-infected and HIV-exposed infants Laserson, Kayla F.
2012
30 Supplement 3 p. A61-A70
nvt p.
artikel
166 Safety of Zostavax™—A cohort study in a managed care organization Baxter, Roger
2012
30 Supplement 3 p. 6636-6641
6 p.
artikel
167 School-located influenza immunization programs: Factors important to parents and students Middleman, Amy B.
2012
30 Supplement 3 p. 4993-4999
7 p.
artikel
168 Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa Tapia, Milagritos D.
2012
30 Supplement 3 p. A79-A85
nvt p.
artikel
169 Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria Giwa, F.J.
2012
30 Supplement 3 p. 6759-6765
7 p.
artikel
170 Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections Horácio, Andreia N.
2012
30 Supplement 3 p. 218-224
7 p.
artikel
171 Simplifying complex sequence information: A PCP-consensus protein binds antibodies against all four Dengue serotypes Bowen, David M.
2012
30 Supplement 3 p. 6081-6087
7 p.
artikel
172 Stability of a formalin-inactivated Rift Valley fever vaccine: Evaluation of a vaccination campaign for cattle in Mozambique Lagerqvist, N.
2012
30 Supplement 3 p. 6534-6540
7 p.
artikel
173 Streptococcus pneumoniae serotypes isolated from the middle ear fluid of Costa Rican children following introduction of the heptavalent pneumococcal conjugate vaccine into a limited population Guevara, Silvia
2012
30 Supplement 3 p. 3857-3861
5 p.
artikel
174 Superior protection conferred by inactivated whole virus vaccine over subunit and DNA vaccines against salmonid alphavirus infection in Atlantic salmon (Salmo salar L.) Xu, Cheng
2012
30 Supplement 3 p. 3918-3928
11 p.
artikel
175 The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains Nico, Dirlei
2012
30 Supplement 3 p. 3169-3179
11 p.
artikel
176 The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: A randomized controlled trial Dagan, Ron
2012
30 Supplement 3 p. 5132-5140
9 p.
artikel
177 The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies Ambrose, Christopher S.
2012
30 Supplement 3 p. 886-892
7 p.
artikel
178 The population based socioeconomic burden of pediatric influenza-associated hospitalization in Hong Kong Chiu, Susan S.
2012
30 Supplement 3 p. 1895-1900
6 p.
artikel
179 The presence of viral subpopulations in an infectious bronchitis virus vaccine with differing pathogenicity – A preliminary study Hewson, Kylie A.
2012
30 Supplement 3 p. 4190-4199
10 p.
artikel
180 The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture–recapture analysis Huang, Wan-Ting
2012
30 Supplement 3 p. 2168-2172
5 p.
artikel
181 The role of nasal IgA in children vaccinated with live attenuated influenza vaccine Ambrose, Christopher S.
2012
30 Supplement 3 p. 6794-6801
8 p.
artikel
182 The structure of HBsAg particles is not modified upon their adsorption on aluminium hydroxide gel Greiner, Vanille J.
2012
30 Supplement 3 p. 5240-5245
6 p.
artikel
183 Three-year duration of immunity in cats vaccinated with a canarypox-vectored recombinant rabies virus vaccine Jas, D.
2012
30 Supplement 3 p. 6991-6996
6 p.
artikel
184 Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study Carraro, G.
2012
30 Supplement 3 p. 1170-1180
11 p.
artikel
185 Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3–IRF3 signaling and type I interferons in dendritic cells Wang, Ce
2012
30 Supplement 3 p. 4790-4799
10 p.
artikel
186 Towards a meningitis free world—Can we eliminate meningococcal meningitis? Davie, Sue
2012
30 Supplement 3 p. B98-B105
nvt p.
artikel
187 Updating the Natural History of Human Papillomavirus and Anogenital Cancers Moscicki, Anna-Barbara
2012
30 Supplement 3 p. F24-F33
nvt p.
artikel
188 Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults Potsch, D.V.
2012
30 Supplement 3 p. 5973-5977
5 p.
artikel
189 Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix ®): Results of two randomized trials Weston, Wayde M.
2012
30 Supplement 3 p. 1721-1728
8 p.
artikel
190 Vaccination with BM86, subolesin and akirin protective antigens for the control of tick infestations in white tailed deer and red deer Carreón, Diana
2012
30 Supplement 3 p. 273-279
7 p.
artikel
191 Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): Impact on the timeliness of uptake of the primary course of DTPa vaccine Wendy, Bissinger
2012
30 Supplement 3 p. 5293-5297
5 p.
artikel
192 Vaccine and Immunization Surveillance in Ontario (VISION) – Using linked health administrative databases to monitor vaccine safety Wilson, Kumanan
2012
30 Supplement 3 p. 6115-6120
6 p.
artikel
193 Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010–2011: Cohort and case–control study Castilla, Jesús
2012
30 Supplement 3 p. 195-200
6 p.
artikel
194 7-Valent pneumococcal conjugate vaccine and otitis media: Effectiveness of a 2-dose versus 3-dose primary series Stoecker, Charles
2012
30 Supplement 3 p. 6256-6262
7 p.
artikel
195 Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for antigen-specific cytotoxic T lymphocyte response stimulation under leukopenic conditions Oliver, Liliana
2012
30 Supplement 3 p. 2963-2972
10 p.
artikel
196 Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease Zitt, Emanuel
2012
30 Supplement 3 p. 931-935
5 p.
artikel
197 Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission Lin, Guang-Jan
2012
30 Supplement 3 p. 2336-2341
6 p.
artikel
                             197 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland